Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Biological | 40 | 2021 | 9469 | 3.190 |
Why?
|
Neoplasms | 60 | 2023 | 22170 | 2.480 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 11 | 2014 | 686 | 2.420 |
Why?
|
Models, Genetic | 27 | 2021 | 3442 | 2.320 |
Why?
|
Models, Theoretical | 27 | 2022 | 3575 | 2.290 |
Why?
|
Drug Resistance, Neoplasm | 28 | 2023 | 5305 | 2.010 |
Why?
|
Evolution, Molecular | 17 | 2021 | 1886 | 1.790 |
Why?
|
Neoplastic Stem Cells | 11 | 2018 | 1347 | 1.700 |
Why?
|
Glioblastoma | 12 | 2023 | 3482 | 1.430 |
Why?
|
Cell Transformation, Neoplastic | 13 | 2015 | 2825 | 1.310 |
Why?
|
Computational Biology | 13 | 2023 | 3518 | 1.300 |
Why?
|
Protein Kinase Inhibitors | 20 | 2023 | 5671 | 1.280 |
Why?
|
Mutation | 60 | 2023 | 30052 | 1.230 |
Why?
|
Epigenesis, Genetic | 14 | 2023 | 3802 | 1.160 |
Why?
|
Stochastic Processes | 15 | 2019 | 355 | 1.160 |
Why?
|
Circadian Clocks | 2 | 2020 | 164 | 1.150 |
Why?
|
Cell Differentiation | 24 | 2023 | 11528 | 1.130 |
Why?
|
Genes, Tumor Suppressor | 11 | 2011 | 1062 | 1.110 |
Why?
|
Software | 7 | 2023 | 4434 | 1.070 |
Why?
|
Piperazines | 11 | 2020 | 2523 | 1.060 |
Why?
|
Biological Evolution | 9 | 2015 | 1071 | 1.050 |
Why?
|
Antineoplastic Agents | 26 | 2021 | 13639 | 1.030 |
Why?
|
Computer Simulation | 20 | 2021 | 6240 | 1.030 |
Why?
|
Cell Lineage | 9 | 2024 | 2555 | 1.010 |
Why?
|
Benzamides | 10 | 2014 | 1370 | 1.000 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 11 | 2024 | 5315 | 0.990 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2449 | 0.960 |
Why?
|
Acrylamides | 3 | 2021 | 260 | 0.940 |
Why?
|
Pyrimidines | 10 | 2014 | 3028 | 0.930 |
Why?
|
Brain Neoplasms | 10 | 2023 | 9031 | 0.850 |
Why?
|
DNA Replication Timing | 2 | 2013 | 34 | 0.820 |
Why?
|
Neoplasm Metastasis | 12 | 2022 | 4915 | 0.810 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2024 | 736 | 0.810 |
Why?
|
Quinazolines | 5 | 2018 | 1371 | 0.770 |
Why?
|
Aniline Compounds | 4 | 2023 | 1069 | 0.770 |
Why?
|
Genetic Heterogeneity | 6 | 2018 | 732 | 0.750 |
Why?
|
Chromosomal Instability | 7 | 2013 | 178 | 0.740 |
Why?
|
DNA Copy Number Variations | 8 | 2021 | 2020 | 0.740 |
Why?
|
Genome, Human | 7 | 2021 | 4425 | 0.740 |
Why?
|
Genetic Fitness | 3 | 2015 | 115 | 0.710 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2021 | 183 | 0.700 |
Why?
|
Lung Neoplasms | 14 | 2024 | 13380 | 0.700 |
Why?
|
Oncogenes | 4 | 2023 | 1222 | 0.700 |
Why?
|
Genetic Drift | 2 | 2018 | 41 | 0.690 |
Why?
|
Breast Neoplasms | 20 | 2023 | 21012 | 0.690 |
Why?
|
Quinazolinones | 1 | 2021 | 221 | 0.670 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2023 | 8547 | 0.660 |
Why?
|
Myeloproliferative Disorders | 5 | 2021 | 613 | 0.640 |
Why?
|
Algorithms | 11 | 2020 | 14031 | 0.640 |
Why?
|
Disease Progression | 24 | 2021 | 13506 | 0.620 |
Why?
|
Fusion Proteins, bcr-abl | 6 | 2015 | 431 | 0.620 |
Why?
|
Models, Statistical | 10 | 2023 | 5079 | 0.620 |
Why?
|
Stem Cells | 10 | 2023 | 3522 | 0.600 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2021 | 1860 | 0.590 |
Why?
|
Humans | 169 | 2024 | 761504 | 0.580 |
Why?
|
Drug Administration Schedule | 7 | 2021 | 4853 | 0.570 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 617 | 0.570 |
Why?
|
DNA Methylation | 9 | 2017 | 4398 | 0.560 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 179 | 0.540 |
Why?
|
Gene Expression Profiling | 9 | 2023 | 9420 | 0.530 |
Why?
|
Clone Cells | 9 | 2021 | 1659 | 0.520 |
Why?
|
Cell Proliferation | 14 | 2021 | 10445 | 0.520 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3201 | 0.520 |
Why?
|
Neoplasm Proteins | 6 | 2016 | 3617 | 0.510 |
Why?
|
Chimerism | 1 | 2016 | 155 | 0.500 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2023 | 926 | 0.490 |
Why?
|
Pancreatic Neoplasms | 3 | 2019 | 5368 | 0.490 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2021 | 618 | 0.480 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2017 | 258 | 0.480 |
Why?
|
Deoxycytidine | 1 | 2019 | 877 | 0.470 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2024 | 11742 | 0.470 |
Why?
|
Keratin-5 | 1 | 2014 | 45 | 0.470 |
Why?
|
Multiple Myeloma | 5 | 2021 | 5146 | 0.460 |
Why?
|
Bayes Theorem | 2 | 2023 | 2330 | 0.450 |
Why?
|
Precancerous Conditions | 2 | 2018 | 980 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2014 | 286 | 0.430 |
Why?
|
Cell Line, Tumor | 22 | 2023 | 16981 | 0.430 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2014 | 302 | 0.410 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2011 | 2425 | 0.400 |
Why?
|
Thiazoles | 3 | 2020 | 1517 | 0.400 |
Why?
|
Genome | 4 | 2017 | 1740 | 0.380 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2011 | 74 | 0.380 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 750 | 0.380 |
Why?
|
Neurofibromin 1 | 2 | 2014 | 190 | 0.370 |
Why?
|
Proteoglycans | 1 | 2014 | 803 | 0.360 |
Why?
|
Biophysical Phenomena | 1 | 2011 | 320 | 0.360 |
Why?
|
Nucleotides | 1 | 2013 | 454 | 0.350 |
Why?
|
Nonlinear Dynamics | 2 | 2015 | 492 | 0.340 |
Why?
|
Gene Silencing | 6 | 2013 | 1509 | 0.330 |
Why?
|
Histones | 2 | 2023 | 2580 | 0.330 |
Why?
|
Myeloid Progenitor Cells | 1 | 2009 | 113 | 0.320 |
Why?
|
DNA, Neoplasm | 4 | 2020 | 1745 | 0.320 |
Why?
|
Medical Oncology | 1 | 2021 | 2321 | 0.320 |
Why?
|
Animals | 49 | 2023 | 168459 | 0.320 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 457 | 0.310 |
Why?
|
BRCA1 Protein | 3 | 2013 | 1155 | 0.310 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1738 | 0.300 |
Why?
|
Cell Nucleus | 2 | 2017 | 2909 | 0.300 |
Why?
|
Linear Models | 2 | 2017 | 5871 | 0.300 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2023 | 1085 | 0.300 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1727 | 0.300 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1063 | 0.290 |
Why?
|
Tumor Microenvironment | 9 | 2024 | 3877 | 0.290 |
Why?
|
Prognosis | 13 | 2022 | 29625 | 0.280 |
Why?
|
Decision Making | 1 | 2021 | 3929 | 0.280 |
Why?
|
Erythrocytes | 1 | 2016 | 2413 | 0.280 |
Why?
|
Game Theory | 2 | 2005 | 23 | 0.270 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2023 | 3613 | 0.270 |
Why?
|
Blast Crisis | 1 | 2007 | 102 | 0.270 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2014 | 1405 | 0.260 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2014 | 2223 | 0.260 |
Why?
|
Receptors, Growth Factor | 1 | 2006 | 326 | 0.250 |
Why?
|
Radiation Dosage | 1 | 2014 | 1958 | 0.250 |
Why?
|
Survival Rate | 7 | 2021 | 12725 | 0.250 |
Why?
|
Drug Synergism | 4 | 2020 | 1755 | 0.250 |
Why?
|
Colon | 1 | 2013 | 1792 | 0.250 |
Why?
|
INDEL Mutation | 2 | 2017 | 266 | 0.230 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2023 | 30 | 0.230 |
Why?
|
Mice | 25 | 2023 | 81525 | 0.230 |
Why?
|
Signal Transduction | 14 | 2023 | 23445 | 0.220 |
Why?
|
Cell Survival | 5 | 2021 | 5791 | 0.220 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 3032 | 0.220 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5789 | 0.210 |
Why?
|
Colorectal Neoplasms | 3 | 2015 | 6935 | 0.210 |
Why?
|
Genetic Variation | 8 | 2017 | 6567 | 0.210 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1896 | 0.210 |
Why?
|
Treatment Outcome | 16 | 2021 | 64680 | 0.200 |
Why?
|
B-Lymphocytes | 2 | 2013 | 4758 | 0.200 |
Why?
|
Chromosome Aberrations | 3 | 2021 | 1768 | 0.200 |
Why?
|
Probability | 5 | 2020 | 2477 | 0.200 |
Why?
|
Janus Kinase 2 | 5 | 2021 | 560 | 0.200 |
Why?
|
Receptor, erbB-2 | 3 | 2021 | 2557 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 4575 | 0.190 |
Why?
|
MyoD Protein | 1 | 2021 | 142 | 0.190 |
Why?
|
HMGA1a Protein | 1 | 2021 | 61 | 0.180 |
Why?
|
Glioma | 2 | 2016 | 3455 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 147 | 0.180 |
Why?
|
Cell Cycle | 4 | 2020 | 2932 | 0.180 |
Why?
|
Urologic Neoplasms | 2 | 2015 | 314 | 0.180 |
Why?
|
Thrombocythemia, Essential | 1 | 2021 | 113 | 0.180 |
Why?
|
Radiation, Ionizing | 1 | 2021 | 251 | 0.180 |
Why?
|
Polycythemia Vera | 1 | 2021 | 161 | 0.170 |
Why?
|
Chromosome Disorders | 1 | 2003 | 497 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2023 | 561 | 0.170 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 1394 | 0.170 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2018 | 310 | 0.170 |
Why?
|
Muscle Development | 1 | 2021 | 259 | 0.170 |
Why?
|
Kinetics | 5 | 2020 | 6374 | 0.170 |
Why?
|
Point Mutation | 3 | 2017 | 1595 | 0.160 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.160 |
Why?
|
Gene Dosage | 4 | 2016 | 1217 | 0.160 |
Why?
|
Cooperative Behavior | 2 | 2005 | 1505 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 899 | 0.160 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2018 | 27 | 0.160 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6814 | 0.160 |
Why?
|
Binding Sites | 2 | 2021 | 6055 | 0.160 |
Why?
|
Models, Immunological | 3 | 2007 | 513 | 0.160 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2013 | 629 | 0.160 |
Why?
|
Apoptosis | 7 | 2021 | 9486 | 0.150 |
Why?
|
Neoplastic Processes | 2 | 2023 | 35 | 0.150 |
Why?
|
Stathmin | 1 | 2018 | 70 | 0.150 |
Why?
|
Maximum Tolerated Dose | 2 | 2018 | 883 | 0.150 |
Why?
|
Paclitaxel | 3 | 2023 | 1732 | 0.150 |
Why?
|
Circadian Rhythm | 2 | 2020 | 2576 | 0.150 |
Why?
|
CpG Islands | 3 | 2017 | 1230 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2023 | 999 | 0.150 |
Why?
|
HCT116 Cells | 1 | 2018 | 404 | 0.150 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 171 | 0.150 |
Why?
|
Female | 37 | 2023 | 392644 | 0.150 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 184 | 0.150 |
Why?
|
Ectoderm | 1 | 2017 | 137 | 0.140 |
Why?
|
DNA Mutational Analysis | 4 | 2021 | 4111 | 0.140 |
Why?
|
Florida | 1 | 2018 | 431 | 0.140 |
Why?
|
RNA-Binding Proteins | 3 | 2021 | 1897 | 0.140 |
Why?
|
Germ Layers | 1 | 2017 | 72 | 0.140 |
Why?
|
Genes, erbB-2 | 2 | 2015 | 162 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2020 | 350 | 0.140 |
Why?
|
Leucovorin | 1 | 2019 | 643 | 0.140 |
Why?
|
Autopsy | 2 | 2012 | 1008 | 0.140 |
Why?
|
Vinblastine | 1 | 2018 | 488 | 0.140 |
Why?
|
Repressor Proteins | 3 | 2018 | 2986 | 0.140 |
Why?
|
Colonic Neoplasms | 2 | 2010 | 2538 | 0.140 |
Why?
|
Sequence Analysis, DNA | 5 | 2021 | 4740 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2024 | 1961 | 0.140 |
Why?
|
Albumins | 1 | 2019 | 575 | 0.130 |
Why?
|
Bone Marrow Neoplasms | 1 | 2017 | 101 | 0.130 |
Why?
|
Population Dynamics | 3 | 2015 | 307 | 0.130 |
Why?
|
Genomics | 5 | 2022 | 5821 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2022 | 2917 | 0.130 |
Why?
|
Cell Death | 2 | 2020 | 1678 | 0.130 |
Why?
|
Recurrence | 4 | 2023 | 8465 | 0.130 |
Why?
|
Survival Analysis | 3 | 2014 | 10090 | 0.130 |
Why?
|
Blotting, Western | 2 | 2021 | 5035 | 0.130 |
Why?
|
Cell Line | 3 | 2021 | 15601 | 0.130 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2017 | 326 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2023 | 1250 | 0.130 |
Why?
|
Receptors, Estrogen | 1 | 2023 | 2208 | 0.130 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10194 | 0.120 |
Why?
|
Proteins | 2 | 2020 | 6032 | 0.120 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 784 | 0.120 |
Why?
|
Sarcoma, Myeloid | 1 | 2015 | 51 | 0.120 |
Why?
|
Phenotype | 8 | 2022 | 16591 | 0.120 |
Why?
|
Mammals | 1 | 2020 | 1132 | 0.120 |
Why?
|
Quinolines | 1 | 2020 | 764 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2013 | 1742 | 0.120 |
Why?
|
Homeodomain Proteins | 3 | 2023 | 2416 | 0.120 |
Why?
|
Selection, Genetic | 3 | 2011 | 868 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1363 | 0.120 |
Why?
|
Polyploidy | 1 | 2015 | 119 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6346 | 0.120 |
Why?
|
Epithelial Cells | 3 | 2024 | 3673 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2019 | 811 | 0.120 |
Why?
|
Blastocyst | 1 | 2017 | 433 | 0.120 |
Why?
|
Cell Transplantation | 1 | 2016 | 472 | 0.120 |
Why?
|
Epidemiology | 1 | 2017 | 279 | 0.120 |
Why?
|
Up-Regulation | 3 | 2020 | 4124 | 0.110 |
Why?
|
STAT Transcription Factors | 1 | 2015 | 188 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2021 | 18252 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15936 | 0.110 |
Why?
|
Fluorouracil | 1 | 2019 | 1641 | 0.110 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2015 | 132 | 0.110 |
Why?
|
Transcription Initiation Site | 1 | 2014 | 188 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 106 | 0.110 |
Why?
|
Down-Regulation | 2 | 2021 | 2919 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2017 | 328 | 0.110 |
Why?
|
Janus Kinases | 1 | 2015 | 248 | 0.110 |
Why?
|
Logistic Models | 2 | 2019 | 13255 | 0.110 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1387 | 0.110 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2013 | 37 | 0.110 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 2016 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2726 | 0.110 |
Why?
|
Remission Induction | 1 | 2019 | 2396 | 0.110 |
Why?
|
Immune System | 2 | 2012 | 796 | 0.110 |
Why?
|
Insulator Elements | 1 | 2013 | 27 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1893 | 0.110 |
Why?
|
Mass Screening | 2 | 2022 | 5428 | 0.100 |
Why?
|
Genomic Instability | 2 | 2021 | 709 | 0.100 |
Why?
|
Drug Interactions | 1 | 2017 | 1416 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 774 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
Aorta | 1 | 2020 | 2042 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2021 | 6132 | 0.100 |
Why?
|
Cluster Analysis | 4 | 2015 | 2707 | 0.100 |
Why?
|
Pancreas | 1 | 2019 | 1691 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2020 | 5796 | 0.100 |
Why?
|
Time Factors | 6 | 2015 | 39967 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5671 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2023 | 12463 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2017 | 858 | 0.100 |
Why?
|
Homeostasis | 1 | 2003 | 3323 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 203 | 0.100 |
Why?
|
DNA Breaks | 1 | 2011 | 47 | 0.100 |
Why?
|
Neoadjuvant Therapy | 2 | 2021 | 2827 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 651 | 0.090 |
Why?
|
Blood-Brain Barrier | 1 | 2018 | 1027 | 0.090 |
Why?
|
Immunotherapy | 2 | 2024 | 4652 | 0.090 |
Why?
|
Physics | 1 | 2011 | 91 | 0.090 |
Why?
|
Austria | 2 | 2021 | 207 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6484 | 0.090 |
Why?
|
Receptors, Notch | 2 | 2016 | 743 | 0.090 |
Why?
|
Phylogeny | 3 | 2020 | 2811 | 0.090 |
Why?
|
Viruses | 2 | 2005 | 375 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2023 | 3612 | 0.090 |
Why?
|
Neoplasm Invasiveness | 3 | 2010 | 3595 | 0.090 |
Why?
|
Microsatellite Instability | 3 | 2017 | 716 | 0.090 |
Why?
|
Genes, erbB-1 | 1 | 2011 | 162 | 0.090 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2226 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.090 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 727 | 0.090 |
Why?
|
Statistical Distributions | 1 | 2010 | 63 | 0.090 |
Why?
|
Bone Marrow | 2 | 2021 | 2911 | 0.090 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2011 | 92 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 946 | 0.090 |
Why?
|
Parity | 1 | 2013 | 927 | 0.090 |
Why?
|
Macrophages | 2 | 2023 | 5769 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 2 | 2014 | 1115 | 0.090 |
Why?
|
Smooth Muscle Tumor | 1 | 2010 | 63 | 0.090 |
Why?
|
Aged | 11 | 2023 | 169289 | 0.080 |
Why?
|
Middle Aged | 14 | 2021 | 220895 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 3 | 2021 | 3396 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8002 | 0.080 |
Why?
|
Drug Resistance | 2 | 2007 | 1596 | 0.080 |
Why?
|
Loss of Heterozygosity | 2 | 2021 | 662 | 0.080 |
Why?
|
Hemodynamics | 1 | 2020 | 4159 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 1374 | 0.080 |
Why?
|
Gene Amplification | 3 | 2023 | 1089 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1756 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1378 | 0.080 |
Why?
|
Alternative Splicing | 1 | 2014 | 1093 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2448 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 2 | 2022 | 2688 | 0.080 |
Why?
|
Poisson Distribution | 1 | 2010 | 504 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1052 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2023 | 255 | 0.080 |
Why?
|
Fibroblasts | 4 | 2023 | 4141 | 0.080 |
Why?
|
Germinal Center | 1 | 2011 | 380 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2012 | 2265 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4026 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.080 |
Why?
|
Blood Coagulation Factors | 1 | 2010 | 365 | 0.080 |
Why?
|
Azepines | 2 | 2020 | 329 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1301 | 0.080 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1258 | 0.070 |
Why?
|
Nucleic Acid Conformation | 1 | 2011 | 902 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2017 | 12795 | 0.070 |
Why?
|
Adipogenesis | 1 | 2010 | 368 | 0.070 |
Why?
|
Aging | 1 | 2006 | 8708 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2014 | 782 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1745 | 0.070 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2020 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2023 | 2510 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2010 | 492 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.070 |
Why?
|
Chromosome Duplication | 2 | 2018 | 75 | 0.070 |
Why?
|
Leiomyosarcoma | 1 | 2010 | 422 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2865 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20098 | 0.060 |
Why?
|
Pulse Therapy, Drug | 2 | 2017 | 37 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2015 | 11121 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9280 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1901 | 0.060 |
Why?
|
ras Proteins | 1 | 2010 | 1054 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 2 | 2019 | 1642 | 0.060 |
Why?
|
Radiation Tolerance | 2 | 2018 | 479 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 7581 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3792 | 0.060 |
Why?
|
Triazoles | 2 | 2020 | 903 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2547 | 0.060 |
Why?
|
DNA Replication | 1 | 2011 | 1418 | 0.060 |
Why?
|
Cohort Studies | 2 | 2021 | 41487 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4936 | 0.060 |
Why?
|
Incidence | 3 | 2014 | 21353 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3537 | 0.060 |
Why?
|
Adult | 11 | 2021 | 221177 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 29874 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2017 | 3639 | 0.050 |
Why?
|
Rats, Inbred ACI | 1 | 2022 | 34 | 0.050 |
Why?
|
Mice, SCID | 2 | 2021 | 2626 | 0.050 |
Why?
|
SOXF Transcription Factors | 1 | 2023 | 31 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2017 | 2049 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4511 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2023 | 262 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12690 | 0.050 |
Why?
|
Disease | 1 | 2007 | 672 | 0.050 |
Why?
|
Endoderm | 1 | 2023 | 160 | 0.050 |
Why?
|
Paracrine Communication | 1 | 2023 | 277 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2011 | 9539 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2018 | 18965 | 0.050 |
Why?
|
Virus Diseases | 2 | 2005 | 718 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 9000 | 0.050 |
Why?
|
Genotype | 3 | 2023 | 12990 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15732 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6228 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39106 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2022 | 4615 | 0.050 |
Why?
|
Models, Psychological | 1 | 2005 | 828 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2010 | 1420 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2822 | 0.050 |
Why?
|
Models, Molecular | 1 | 2011 | 5439 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2021 | 2416 | 0.050 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2004 | 828 | 0.050 |
Why?
|
Altruism | 1 | 2002 | 208 | 0.050 |
Why?
|
Methylation | 1 | 2023 | 1084 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4174 | 0.040 |
Why?
|
Registries | 2 | 2014 | 8224 | 0.040 |
Why?
|
Myoblasts | 1 | 2021 | 231 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2010 | 1654 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 800 | 0.040 |
Why?
|
Cell Division | 2 | 2006 | 4465 | 0.040 |
Why?
|
Epistasis, Genetic | 1 | 2022 | 352 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 285 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12441 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2811 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4243 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8529 | 0.040 |
Why?
|
Male | 8 | 2019 | 360804 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2021 | 670 | 0.040 |
Why?
|
Young Adult | 3 | 2023 | 59243 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2004 | 1251 | 0.040 |
Why?
|
Estrogen Receptor Modulators | 1 | 2018 | 58 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 871 | 0.040 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 376 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2021 | 542 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11076 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58976 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3849 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2004 | 1784 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7594 | 0.040 |
Why?
|
DNA Restriction Enzymes | 1 | 2017 | 550 | 0.040 |
Why?
|
Gene Deletion | 2 | 2015 | 2665 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4876 | 0.040 |
Why?
|
Transcription Factors | 3 | 2023 | 12128 | 0.030 |
Why?
|
Markov Chains | 1 | 2020 | 966 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1668 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1096 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2004 | 1802 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 672 | 0.030 |
Why?
|
Alleles | 3 | 2020 | 6863 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2017 | 2571 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4244 | 0.030 |
Why?
|
Pyridines | 2 | 2020 | 2875 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3429 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 370 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 496 | 0.030 |
Why?
|
Reward | 1 | 2002 | 971 | 0.030 |
Why?
|
E2F3 Transcription Factor | 1 | 2015 | 36 | 0.030 |
Why?
|
K562 Cells | 1 | 2017 | 642 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2021 | 1135 | 0.030 |
Why?
|
Cell Movement | 2 | 2021 | 5203 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3778 | 0.030 |
Why?
|
Mathematical Concepts | 1 | 2015 | 73 | 0.030 |
Why?
|
Diploidy | 1 | 2015 | 132 | 0.030 |
Why?
|
NF-kappa B | 1 | 2023 | 2490 | 0.030 |
Why?
|
Haploidy | 1 | 2015 | 126 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 727 | 0.030 |
Why?
|
Chromosomes, Fungal | 1 | 2015 | 111 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2018 | 3466 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2015 | 107 | 0.030 |
Why?
|
Interleukin-11 | 1 | 2014 | 58 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2015 | 140 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2021 | 3087 | 0.030 |
Why?
|
Dioxygenases | 1 | 2017 | 345 | 0.030 |
Why?
|
DNA Fingerprinting | 1 | 2014 | 114 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26125 | 0.030 |
Why?
|
MicroRNAs | 1 | 2010 | 3816 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1469 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2014 | 277 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 517 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2116 | 0.030 |
Why?
|
Glycolysis | 1 | 2018 | 835 | 0.030 |
Why?
|
DNA Repair | 2 | 2017 | 2045 | 0.030 |
Why?
|
Lung | 2 | 2024 | 10000 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1835 | 0.030 |
Why?
|
Primary Myelofibrosis | 1 | 2015 | 209 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 368 | 0.030 |
Why?
|
Gene Library | 1 | 2015 | 1059 | 0.030 |
Why?
|
DNA | 2 | 2017 | 7212 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1459 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2015 | 582 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2115 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2015 | 1991 | 0.020 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 1 | 2011 | 21 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2014 | 638 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8181 | 0.020 |
Why?
|
Estradiol | 1 | 2018 | 1937 | 0.020 |
Why?
|
Child | 3 | 2023 | 80153 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6075 | 0.020 |
Why?
|
Aneuploidy | 1 | 2015 | 551 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 162 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 571 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.020 |
Why?
|
Intestines | 1 | 2020 | 1909 | 0.020 |
Why?
|
Drug Substitution | 1 | 2013 | 290 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4580 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2015 | 823 | 0.020 |
Why?
|
Myometrium | 1 | 2010 | 174 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 88319 | 0.020 |
Why?
|
Lymphocytes | 1 | 2017 | 2612 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2010 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2469 | 0.020 |
Why?
|
Sheep | 1 | 2011 | 1440 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3448 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 749 | 0.020 |
Why?
|
Receptors, IgE | 1 | 2010 | 375 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2013 | 805 | 0.020 |
Why?
|
Placenta | 1 | 2017 | 1709 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 452 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3606 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2651 | 0.020 |
Why?
|
Stromal Cells | 1 | 2013 | 1330 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2446 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8320 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 314 | 0.020 |
Why?
|
HIV-1 | 1 | 2004 | 6863 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2057 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23742 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 1661 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3113 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4948 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 2010 | 926 | 0.020 |
Why?
|
United States | 2 | 2014 | 72334 | 0.020 |
Why?
|
Germany | 1 | 2008 | 875 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1886 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2915 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4346 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2632 | 0.020 |
Why?
|
Chromium Radioisotopes | 1 | 2004 | 34 | 0.020 |
Why?
|
Genes, tat | 1 | 2004 | 15 | 0.020 |
Why?
|
Genes, gag | 1 | 2004 | 55 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1136 | 0.020 |
Why?
|
Mice, Nude | 1 | 2011 | 3615 | 0.010 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2004 | 92 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2008 | 495 | 0.010 |
Why?
|
Pyrazoles | 1 | 2015 | 2009 | 0.010 |
Why?
|
Prospective Studies | 2 | 2023 | 54425 | 0.010 |
Why?
|
Brain | 1 | 2011 | 27112 | 0.010 |
Why?
|
Risk Factors | 1 | 2011 | 74206 | 0.010 |
Why?
|
Genes, Suppressor | 1 | 2004 | 47 | 0.010 |
Why?
|
Infant | 1 | 2006 | 36192 | 0.010 |
Why?
|
Group Processes | 1 | 2005 | 228 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9326 | 0.010 |
Why?
|
Population Density | 1 | 2004 | 193 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 42230 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2529 | 0.010 |
Why?
|
Cell Physiological Phenomena | 1 | 2004 | 150 | 0.010 |
Why?
|
Cross Reactions | 1 | 2005 | 817 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22169 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 707 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5869 | 0.010 |
Why?
|
Host-Parasite Interactions | 1 | 2004 | 300 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6485 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3422 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3305 | 0.010 |
Why?
|
Virulence | 1 | 2005 | 1303 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2004 | 397 | 0.010 |
Why?
|
Tumor Escape | 1 | 2004 | 370 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 2004 | 825 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2005 | 988 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14605 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2819 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7856 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7396 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9606 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14414 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2005 | 974 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4003 | 0.010 |
Why?
|
Genetics, Population | 1 | 2004 | 937 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9177 | 0.010 |
Why?
|
HIV Infections | 1 | 2004 | 17351 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9318 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15266 | 0.010 |
Why?
|
HIV | 1 | 2005 | 1582 | 0.010 |
Why?
|
Virus Replication | 1 | 2004 | 2435 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2005 | 80636 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2004 | 3162 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22176 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2005 | 2303 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13446 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36426 | 0.010 |
Why?
|